Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Cai C, Lin Y, Yu C.

Can J Gastroenterol Hepatol. 2019 Aug 20;2019:2096161. doi: 10.1155/2019/2096161. eCollection 2019.

2.

Convolutional neural network for the diagnosis of early gastric cancer based on magnifying narrow band imaging.

Li L, Chen Y, Shen Z, Zhang X, Sang J, Ding Y, Yang X, Li J, Chen M, Jin C, Chen C, Yu C.

Gastric Cancer. 2019 Jul 22. doi: 10.1007/s10120-019-00992-2. [Epub ahead of print]

PMID:
31332619
3.

Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway.

Chen Y, Chen X, Gao J, Xu C, Xu P, Li Y, Zhu Y, Yu C.

FASEB J. 2019 Jul 16:fj201900643RRR. doi: 10.1096/fj.201900643RRR. [Epub ahead of print]

PMID:
31311301
4.

Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Cai C, Song X, Chen Y, Chen X, Yu C.

Hepatol Int. 2019 Jul 9. doi: 10.1007/s12072-019-09964-1. [Epub ahead of print]

PMID:
31290072
5.

Hepatic steroid sulfatase critically determines estrogenic activities of conjugated equine estrogens in human cells in vitro and in mice.

Feng Y, Xie Y, Xu M, Li L, Selcer KW, Oberly PJ, Poloyac SM, Wang H, Li C, Dong F, Yu C, Xie W.

J Biol Chem. 2019 Aug 9;294(32):12112-12121. doi: 10.1074/jbc.RA119.009181. Epub 2019 Jun 19.

PMID:
31217279
6.

Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model.

Xu C, Chang T, Du Y, Yu C, Tan X, Li X.

Environ Toxicol Pharmacol. 2019 Aug;70:103202. doi: 10.1016/j.etap.2019.103202. Epub 2019 May 30.

PMID:
31173966
7.

Long Noncoding RNA p53-Stabilizing and Activating RNA Promotes p53 Signaling by Inhibiting Heterogeneous Nuclear Ribonucleoprotein K deSUMOylation and Suppresses Hepatocellular Carcinoma.

Qin G, Tu X, Li H, Cao P, Chen X, Song J, Han H, Li Y, Guo B, Yang L, Yan P, Li P, Gao C, Zhang J, Yang Y, Zheng J, Ju HQ, Lu L, Wang X, Yu C, Sun Y, Xing B, Ji H, Lin D, He F, Zhou G.

Hepatology. 2019 May 30. doi: 10.1002/hep.30793. [Epub ahead of print]

PMID:
31148184
8.

CYP3A suppression during diet-induced nonalcoholic fatty liver disease is independent of PXR regulation.

Zeng H, Lin Y, Gong J, Lin S, Gao J, Li C, Feng Z, Zhang H, Zhang J, Li Y, Yu C.

Chem Biol Interact. 2019 Aug 1;308:185-193. doi: 10.1016/j.cbi.2019.05.038. Epub 2019 May 24.

PMID:
31132328
9.

Estrogen sulfotransferase in the metabolism of estrogenic drugs and in the pathogenesis of diseases.

Barbosa ACS, Feng Y, Yu C, Huang M, Xie W.

Expert Opin Drug Metab Toxicol. 2019 Apr;15(4):329-339. doi: 10.1080/17425255.2019.1588884. Epub 2019 Mar 18.

PMID:
30822161
10.

Alcohol Consumption and the Risk of Gastroesophageal Reflux Disease: A Systematic Review and Meta-analysis.

Pan J, Cen L, Chen W, Yu C, Li Y, Shen Z.

Alcohol Alcohol. 2019 Jan 1;54(1):62-69. doi: 10.1093/alcalc/agy063.

PMID:
30184159
11.

Systematic review of the relationship of Helicobacter pylori infection with geographical latitude, average annual temperature and average daily sunshine.

Lu C, Yu Y, Li L, Yu C, Xu P.

BMC Gastroenterol. 2018 Apr 17;18(1):50. doi: 10.1186/s12876-018-0779-x. Review.

12.

Risk for the development of non-alcoholic fatty liver disease: A prospective study.

Wang J, Ma L, Chen S, Xu L, Miao M, Yu C, Li Y, Xu C.

J Gastroenterol Hepatol. 2018 Aug;33(8):1518-1523. doi: 10.1111/jgh.14105. Epub 2018 Mar 25.

PMID:
29381226
13.

Helicobacter Pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta-analysis.

Cen L, Pan J, Zhou B, Yu C, Li Y, Chen W, Shen Z.

Helicobacter. 2018 Feb;23(1). doi: 10.1111/hel.12457. Epub 2017 Dec 20. Review.

PMID:
29266548
14.

Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway.

Li M, Xu C, Shi J, Ding J, Wan X, Chen D, Gao J, Li C, Zhang J, Lin Y, Tu Z, Kong X, Li Y, Yu C.

Gut. 2018 Dec;67(12):2169-2180. doi: 10.1136/gutjnl-2017-313778. Epub 2017 Sep 6.

15.

Caveolin1 protects against diet induced hepatic lipid accumulation in mice.

Li M, Chen D, Huang H, Wang J, Wan X, Xu C, Li C, Ma H, Yu C, Li Y.

PLoS One. 2017 Jun 1;12(6):e0178748. doi: 10.1371/journal.pone.0178748. eCollection 2017.

16.
17.

Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis.

Chen Y, Huang H, Xu C, Yu C, Li Y.

Int J Mol Sci. 2017 Jan 16;18(1). pii: E21. doi: 10.3390/ijms18010021.

18.

Serum apoB levels independently predict the development of non-alcoholic fatty liver disease: A 7-year prospective study.

Wang J, Zhu W, Huang S, Xu L, Miao M, Wu C, Yu C, Li Y, Xu C.

Liver Int. 2017 Aug;37(8):1202-1208. doi: 10.1111/liv.13363. Epub 2017 Feb 11.

PMID:
28106941
19.

Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter retrospective study over 7 years.

Li L, Ke Y, Yu C, Li G, Yang N, Zhang J, Li Y.

Helicobacter. 2017 Jun;22(3). doi: 10.1111/hel.12373. Epub 2017 Jan 18.

PMID:
28098401
20.

Epidemiological Trends in Colorectal Cancer in China: An Ecological Study.

Zhu J, Tan Z, Hollis-Hansen K, Zhang Y, Yu C, Li Y.

Dig Dis Sci. 2017 Jan;62(1):235-243. doi: 10.1007/s10620-016-4362-4. Epub 2016 Oct 31.

PMID:
27796769

Supplemental Content

Loading ...
Support Center